Genomic characterization of high-risk non-muscle invasive bladder cancer

par Meeks, Joshua J., Carneiro, Benedito A., Pai, Sachin G., Oberlin, Daniel T., Rademaker, Alfred, Fedorchak, Kyle, Balasubramanian, Sohail, Elvin, Julia, Beaubier, Nike, Giles, Francis J.
Publié dans Oncotarget (2016)

Loss of heterozygosity as a marker of homologous repair deficiency in multiple myeloma: a role for PARP inhibition?

par Pawlyn, Charlotte, Loehr, Andrea, Ashby, Cody, Tytarenko, Ruslana, Deshpande, Shayu, Sun, James, Fedorchak, Kyle, Mughal, Tariq, Davies, Faith E., Walker, Brian A., Morgan, Gareth J.
Publié dans Leukemia (2018)

Comprehensive Genomic Profiling of Esthesioneuroblastoma Reveals Additional Treatment Options

par Gay, Laurie M., Kim, Sungeun, Fedorchak, Kyle, Kundranda, Madappa, Odia, Yazmin, Nangia, Chaitali, Battiste, James, Colon‐Otero, Gerardo, Powell, Steven, Russell, Jeffery, Elvin, Julia A., Vergilio, Jo‐Anne, Suh, James, Ali, Siraj M., Stephens, Philip J., Miller, Vincent A., Ross, Jeffrey S.
Publié dans Oncologist (2017)